Monoclonal Antibodies: Stanford Academia-Industry Collaboration – Video

Posted: Published on December 8th, 2011

This post was added by Dr. Richardson



August 22, 2007 presentation by Ron Levy for the Stanford School of Medicine Medcast lecture series. Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective

See the rest here:
Monoclonal Antibodies: Stanford Academia-Industry Collaboration - Video

Related Posts
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.